Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms

scientific article published on 01 June 1995

Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.270.25.15059
P698PubMed publication ID7797488

P2093author name stringB Z Levi
G Neufeld
T Cohen
S M Greenberg
H Gitay-Goren
S Gengrinovitch
T E Maione
P Rockwell
P433issue25
P407language of work or nameEnglishQ1860
P304page(s)15059-15065
P577publication date1995-06-01
P1433published inJournal of Biological ChemistryQ867727
P1476titlePlatelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms
P478volume270

Reverse relations

cites work (P2860)
Q742617662.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis
Q24303828An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
Q35048828Analysis of the role of chemokines in angiogenesis.
Q35196548Angiogenesis and antiangiogenic strategies in pancreatic cancer
Q36308980Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo
Q36166483Angiogenesis inhibitors found within the haemostasis pathway.
Q34587184Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma
Q34786603Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model
Q93353440Antiangiogenic Gene Therapy in Cancer
Q30864689Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis
Q33698057CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3
Q42256799Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis
Q26778691Chemokine Regulation of Angiogenesis During Wound Healing
Q30438032Chemokines as mediators of neovascularization
Q74446280Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells
Q33426878Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells
Q73031500Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2
Q92403252Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model
Q36489766Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey
Q40632344Fibroblast growth factor receptor‐1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: A role for protein kinase A
Q35540003Generation and Characterization of a New Monoclonal Antibody Against CXCL4.
Q40915145Growth factors in angiogenesis: current interest and therapeutic potential
Q38418286Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
Q52717949Human Cancer and Platelet Interaction, a Potential Therapeutic Target.
Q91645673Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization
Q35743028Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy
Q37364433MKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice
Q42532137Megakaryocytes regulate the quiescence of hematopoietic stem cells through PF4: 2013 ASH meeting highlights
Q40915825Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs.
Q37518830Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
Q74307955PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells
Q36688537Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India
Q51032187Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.
Q90261049Platelet activation in experimental murine neonatal pulmonary hypertension
Q37705023Platelet-derived chemokines: pathophysiology and therapeutic aspects
Q37734218Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria
Q36960001Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology.
Q35300661Role of vascular permeability factor/vascular endothelial growth factor in eye disease
Q84779952Serum protein signature may improve detection of ductal carcinoma in situ of the breast
Q41140250Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Q33912018Target molecules for anti-angiogenic therapy: from basic research to clinical trials
Q30441368The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis
Q28547610The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control
Q57812382The Role of Chemokines in Wound Healing
Q40127968The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells
Q24291904The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells
Q34425462The hemostatic system and angiogenesis in malignancy.
Q37863514The role of chemokines and their receptors in angiogenesis
Q64096591Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma
Q36292182Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

Search more.